This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Mark's Most Recent Article

The Run-Up Trade: Biodel's Insulin Trial Results

05/30/13 - 08:00 AM EDT

Biodel shares should move higher ahead of insulin trial results in the third quarter.

read more >

Other Articles by Mark

Free Reports

Alexza Pharma: Run-Up Trade Into December's Approval Decisions

11/20/12 - 08:03 AM EST

Alexza expects US and European regulators to announce approval decisions in December.

read more >
Celsion: Run-Up Trade Into Thermodox Results

11/14/12 - 07:01 AM EST

Traders are already bidding up shares of Celsion in anticipation of pivotal trial results.

read more >
Short Trade: Supernus IPO Lock-Up

10/31/12 - 07:00 AM EDT

Supernus share should fall now that 10 million shares under lock-up can now be sold.

read more >
How to Prep for the Inevitable Bursting of the Biotech Stock Bubble

10/17/12 - 07:00 AM EDT

Traders need to be less cocky and more prepared for when stocks fall.

read more >
AP Pharma, Delcath Systems: FDA 'Acceptance' Run-Up Trades

10/09/12 - 07:05 AM EDT

The biotech bull market has created a new category of swing trade catalysts.

read more >
How to Trade Hemispherx Even If You Hate the Stock

10/02/12 - 10:48 AM EDT

Biotech swing trader Mark Messier warns to look at Hemispherx as a short-term trade, not an investment.

read more >
Zogenix: Three Shots At Run-Up Trade

09/26/12 - 08:00 AM EDT

Get in Zogenix early before other traders start speculating over its chronic pain drug Zohydro.

read more >
Acadia Pharma, Sarepta Therapeutics: How to Trade Into Trial Results

09/19/12 - 07:31 AM EDT

Biotech trader Mark Messier explains how to position trades ahead of two important biotech clinical trials.

read more >
Dynavax: The BioRunUp Trade Into An FDA Panel

09/11/12 - 11:34 AM EDT

Biotech trader Mark Messier explains how to swing trade Dynavax into a Nov. 14 FDA advisory panel.

read more >
Page 2 of 2
Next >
Top Rated Stocks Top Rated Funds Top Rated ETFs